List of accepted abstracts for the 22nd International Symposium
Please Note: To be eligible to participate in the poster presentation competition make sure your CRSIC membership is not expiring before March 02, 2024.
The first 100 posters in the list will be presented on Day-1 (29-Feb-2024)
Sr. No. 101-194 posters will be presented on Day-2 (01-Mar-2024)
Sr. | Abstract title | |
To be presented on Day-1 29-Feb-2024 |
||
1 | 3D printed microneedle patches for minimally invasive simultaneous transdermal delivery and detection of melatonin from interstitial fluid | |
2 |
|
|
3 | A smart pH responsive PTL loaded mesoporous silica nanoparticles for breast cancer therapy | |
4 | Advancing Wound Care in diabetes through novel Doxycycline Hydrochloride (DOX HCl) loaded Filmogenic Solutions | |
5 | An emerging platform for ferulic acid loaded nanostructured lipid carrier based drug delivery system for solubility enhancement and its antihypertensive activity | |
6 | An in vitro –in vivo investigation of kaempferol loaded ethosomal gel in wound healing | |
7 | An influence of formulation parameters on physical characteristics of self-assembling liposomes (leciplex®) | |
8 | Apixaban solid dispersion approach for solubility and bioavailability enhancement | |
9 | Aptamer tethered hetero-polymer conjugated mesoporous silica nanoparticles (MSNPs) mediated delivery of dual siRNA to induce apoptosis in breast cancer cells | |
10 | Aptamer-tethered hyperbranched bis-MPA polyester dendrimers for targeted delivery of siRNA and gene silencing in breast cancer cells | |
11 | Artificial in-vitro Blood-Brain Barrier Model for Preclinical Screen | |
12 | Assessment of co-delivery of phytoconstituent and immunosuppressant in nanoemulsion based hydrogel for therapeutic management of psoriasis | |
13 | Bioenhancer synergistically increases the permeation of Lopinavir via phospholipid complexation | |
14 | Bioinspired long-acting mucoadhesive gastric patch for Levothyroxine delivery | |
15 | Cationic nanocarriers for carrying macromolecular cargo | |
16 | Chitosan-gum tragacanth gated mesoporous silica nanoparticles encapsulating Berbamine for targeted release in colon cancer | |
17 | Clotrimazole loaded mesoporous silica nanoparticles based gel for the management of cutaneous candidiasis: A comprehensive study on design, development and optimization for topical delivery | |
18 | Co-crystal with different co-former to enhance the solubility and bioavailability | |
19 | Co-delivery of carbamide-luliconazole niosomes for the management of superficial Tinea infections | |
20 | Computational approach toward the identification of novel genetic targets for hepatic cancer | |
21 | Cyclodextrin-nanosponge-based in situ hydrogel for the co-delivery of the effective combinatorial drug regimen towards breast cancer therapy | |
22 | Cytotoxic efficacies of Manilkara zapota extract against MCF-7 cell line | |
23 | Decorated combinatorial nanostructured lipid carriers for the treatment of triple-negative breast cancer | |
24 | Deep eutectic solvent: a promising vehicle for the design of ivermectin microemulgel formulation | |
25 | Design and characterization of SLN loaded transdermal patch for treatment of psoriasis | |
26 | Design and development of cyclodextrin nanosponges-based in situ gelling systems to co-deliver polyphenols for vaginal candidiasis therapy | |
27 | Design and development of Cytarabine-loaded trehalose coated iron oxide nanoparticles: Evaluating its in vitro to in vivo anticancer activity | |
28 | Design and development of lipid based self-emulsifying formulation of Andrographis paniculata by fluidized bed melt granulation technique | |
29 | Design and development of mucoadhesive paliperidone nanoformulations for nasal delivery | |
30 | Design and Evaluation of Osmotic controlled release oral drug delivery system of Carbamazepine by QbD approach | |
31 | Design, development and characterization of Clopidogrel bisulphate incorporated nasal in-situ gelling system for ischemic stroke | |
32 | Design, development and characterization of Boswellia serrata loaded ethosomal gel for anti-inflammatory potential | |
33 | Design, development and characterization of multiparticulate floating drug delivery system of Nintedanib | |
34 | Design, development, and evaluation of cilnidipine ODT using co-processed excipient | |
35 | Development and characterization of herbal nanoparticles of Genistein for the treatment of hepatocellular carcinoma | |
36 | Development and characterization of inhaled formulation for the treatment of Pulmonary fibrosis | |
37 | Development and characterization of nanocarrier loaded microneedles for the Psoriatic arthritis | |
38 | Development and characterization of novel lipidic nanocarriers: A breakthrough approach to Enhance drug permeation and bioavailability | |
39 | Development and evaluation of biocompatible PLGA-gelatin copolymer for 3D printing application | |
40 | Development and evaluation of Lacidipine -phospholipid complex | |
41 | Development and evaluation of Lysozyme loaded Aquasome as a novel carrier for delivery of protein molecule through dry powder inhaler | |
42 | Development and evaluation of multiparticulate dosage form of teneligliptin (IR) and metformin (ER) for sprinkle application | |
43 | Development and evaluation of nasal delivery system of carbamazepine | |
44 | Development and evaluation of novel ionic liquid- polymer based hybrid nanoformulation of curcumin | |
45 | Development and evaluation of Olanzapine sublingual film by QbD approach | |
46 | Development and evaluation of Oral film for attention deficit hyperactivity disorder. | |
47 | Development and evaluation of Verapamil HCl extended-release pellets using fluidized bed processor | |
48 | Development and optimization of Nanogel containing ion chelator for the treatment of chronic wound | |
49 | Development and optimization of Proliposome based Dry Powder Inhalation for Chronic Obstructive Pulmonary Disease | |
50 | Development and optimization of multi-particulate system for nasal delivery of Cilnidipine | |
51 | Development and QbD based optimization of VEGFR inhibitor loaded lipid emulsion system for lung cancer treatment | |
52 | Development of a MARS-based vector system for monoclonal antibody production in CHO cells | |
53 | Development of Cocrystals of Nintedanib for the enhancement of bioavailability | |
54 | Development of Cubosome-loaded topical spray dressing of kojic acid dipalmitate for wound healing | |
55 | Development of herbal formulation for inflammation management | |
56 | Development of Nanostructured Lipid Carriers of Allantoin for wound healing. | |
57 | Development of oral thin film for fixed dose composition | |
58 | Development of silver nanoparticle incorporated core-shell nanofibers for diabetic foot ulcer management | |
59 | Development of stable anti-leukemic drug-loaded novel lipid-based drug product | |
60 | Development of targeted inhalation formulations with combination of anti-TB drugs | |
61 | Development of triple-layered nanofibrous bandage as a wound dressing material | |
62 | Development, characterization and in-vivo potential of thrombus targeted Abciximab coated mesoporous silica nanoparticles in thrombotic event | |
63 | Development, characterization, and in-vitro evaluation of inhalable hyaluronic acid-decorated Chitosan–PLGA nanoparticles for targeted Erlotinib hydrochloride delivery in non-small cell lung cancer | |
64 | Development, evaluation, and optimization of Microsponge-loaded Clotrimazole Lipstick for controlled release: An innovative approach to combat Lip Fungal Infections | |
65 | DOE assisted formulation and evaluation of ethosome loaded nanogel of Karanjin for psoriasis | |
66 | DOE assisted formulation development and evaluation of niosomes loaded in-situ gel for nose to brain drug delivery | |
67 | Domperidone electrospun nanofiber mats: A novel approach for ultrafast drug delivery technologies | |
68 | Dual ligand surface modified Stevioside loaded nanostructured lipid carriers for effective targeting of breast cancer | |
69 | Effect of oxygen generators on Indocyanine green and IR 820 mediated phototherapy against oral cancer | |
70 | Engineering of modified chitosan encased polymersomes in effective management of glioblastoma multiforme through lactoferrin integration | |
71 | Enhancement in brain targeting of hydrophilic drug through protein functionalized lipid-drug conjugated nanoparticles: In-silico screening, formulation development and in-vivo studies | |
72 | Enhancement of solubility of celecoxib using different solubility enhancement technique | |
73 | Enhancing oral bioavailability: Synthesis, characterization and in-vitro evaluation of a trypsin- resistant Salmon calcitonin analog | |
74 | Exploration of curcumin-ascorbic acid cocrystal-based formulations for enhanced physico-technological attributes | |
75 | Exploring potential of combinatorial therapy of curcumin and cyclosporin in biocompatible lipomeric hydrogel for Rheumatoid Arthritis | |
76 | Exploring the therapeutic potential of HUGLP-1 loaded formulation in Type-2 Diabetes Mellitus: From preparation to in vivo assessment | |
77 | Fabrication and characterization of depot parenteral formulation for treatment of mental disorder | |
78 | Fabrication and characterization of topical dorzolamide loaded nanoparticles using Box-Behnken design | |
79 | Fabrication and evaluation of long-acting Primaquine prodrug loaded polymeric nanorods prepared by mechanical stretching | |
80 | Fabrication of solid dispersion incorporated Indomethacin Oro-dispersible tablet to improve its dissolution | |
81 | Fabrication, optimization, and characterization of drug-loaded nanostructured lipid carriers for the treatment of chronic wounds | |
82 | Fast dissolving oral films of Dapoxetine hydrochloride using solvent-casting method for improved patient compliance | |
83 | Film formulation for value addition in wound dressing for effective exudate management | |
84 | Formulating a self-emulsifying drug delivery system of Oroxylum indicum extract for immuno-stimulant activity | |
85 | Formulating freezing mix for cryopreservation of A549 spheroids | |
86 | Formulation and evaluation of Carvedilol loaded Proliposome to improve bioavailability | |
87 | Formulation and characterization of nanovesicular system containing antifungal drug. | |
88 | Formulation and characterization of Empagliflozin: Metformin cocrystals that enhance the biopharmaceutical properties of the drug | |
89 | Formulation and characterization of long-acting biodegradable anti-VEGF loaded implant for the treatment of AMD | |
90 | Formulation and characterization of mirtazapine loaded cubosomal in-situ gel for intranasal delivery. | |
91 | Formulation and characterization of topical herbal nanoemulgel for the management of Rheumatoid Arthritis | |
92 | Formulation and development of long-circulating liposomes of Voriconazole for the treatment of systemic fungal infections | |
93 | Formulation and development of solidified deep eutectic solvent for enhancement of solubility and oral bioavailability of poorly water-soluble drug Zileuton | |
94 | Formulation and evaluation of a nanosuspension based thermoreversible in situ nasal gel of an antipsychotic drug using statistical design | |
95 | Formulation and evaluation of Besifloxacin HCl Solid dispersion incorporated Ophthalmic film | |
96 | Formulation and evaluation of Brinzolamide β-cyclodextrin nanosponges for treatment of glaucoma | |
97 | Formulation and evaluation of Clozapine buccal patch as novel drug delivery for antipsychotic effect | |
98 | Formulation and evaluation of core shell nanoparticle laden in situ gel for corneal neovascularization | |
99 | Formulation and evaluation of Esomeprazole magnesium trihydrate loaded microspheres for treatment of ulcers. | |
100 | Formulation and evaluation of herbal skin care preparation containing extracts of Turmeric Rhizome and Berberis Root at which shea butter as an excipient | |
To be presented on Day-2 01-March-2024 |
||
101 | Formulation and evaluation of in situ gel for nose to brain drug delivery | |
102 | Formulation and evaluation of liquisolid tablets of poorly soluble Voriconazol | |
103 | Formulation and evaluation of mucoadhesive nanocarrier gel for vaginal candidiasis | |
104 | Formulation and evaluation of mucoadhesive probiotic tablet for recolonization of vaginal microbiota | |
105 | Formulation and evaluation of ocular mucoadhesive nanocarrier gel for bacterial keratitis | |
106 | Formulation and evaluation of orodispersible film of Piroxicam (BCS class II drug) | |
107 | Formulation and evaluation of pediatric dosage form using Loratadine ionic liquid salt | |
108 | Formulation and evaluation of Proniosomal oral delivery of Irbesartan | |
109 | Formulation and evaluation of Quercetin ethosomal hydrogel for topical delivery system | |
110 | Formulation and evaluation of Selegiline loaded microneedle array patch for depression disorder | |
111 | Formulation and evaluation of skin care preparation containing extract of Curcuma longa and Berberis aristasta | |
112 | Formulation and evaluation of solid dispersion-based tablet of Voriconazole | |
113 | Formulation and evaluation of solid self microemulsifying drug delivery system of celecoxib. | |
114 | Formulation and evaluation of topical drug delivery system for management of rheumatoid arthritis | |
115 | Formulation and in-vitro evaluation of the therapeutic potential of Bacillus coagulans BCM9 containing probiotic herbal toothpaste | |
116 | Formulation and optimization of drug loaded solid lipid nanoparticles for the treatment of Tuberculosis | |
117 | Formulation development and evaluation of Indian royal jelly – jam and chewable tablets as nutraceutical products | |
118 | Formulation development and evaluation of nanocrystals loaded in mucoadhesive microspheres for solubility enhancement of Zingerone | |
119 | Formulation development of Drotaverine HCl loaded sustained release microspheres of chitosan and its thiolated derivatives | |
120 | Formulation of a sustained release transdermal system for Spasticity | |
121 | Formulation of polyherbal emulgel by quality by design (QbD) approach for Alopecia | |
122 | Formulation, optimization and characterization of HA-SeNPs loaded hydrogel for Psoriasis management using QbD-based approach | |
123 | Formulation, optimization and evaluation of bile salt based nano vesicular carriers for topical delivery of Posaconazole | |
124 | Formulation, development & characterization of floating microspheres of Tizanidine hydrochloride. | |
125 | Harnessing the potential of calcium channel blocker against Alzheimer’s disease using intranasal thermosensitive in situ gelling system | |
126 | Hollow microneedle patches: A transdermal innovation for Insulin delivery | |
127 | Hot melt extrusion of poorly soluble Ritonavir using Poloxamer | |
128 | Inclusion complexation: An effective approach to enhance stability of Tenofovir Disoproxil Fumarate | |
129 | Industrially feasible formulation strategies for enhancing oral bioavailability of BCS class II drugs | |
130 | Inhalable Clofazimine nanoclusters for treatment of Tuberculosis in mice | |
131 | Innovating hair wellness: Crafting an advanced polyherbal shampoo with integrated development, evaluation, optimization, and comparative studies | |
132 | Integrating nanofiber structural precision and injectable hydrogels for enhanced healing in volumetric muscle loss: A unified therapeutic strategy | |
133 | Intranasal transfersomes based in situ gel for enhanced brain distribution | |
134 | Investigating the effect of drug loading process parameters for mesoporous silica nanoparticles using Taguchi design of experiment method | |
135 | Investigation into development of Gamma-Oryzanol solid-SMEDDS for hypercholesterolemia | |
136 | Investigation of impact of lipids on the development of Doxorubicin HCl loaded UFA-NP | |
137 | Investigation on the potential of liquisolid compact incorporated in mucoadhesive vaginal tablets for solubility enhancement of Metronidazole | |
138 | Investigations on role of penetration enhancers to improve permeability of a model drug for transdermal delivery | |
139 | Khellin loaded MCM-48 mesoporous silica nanocarriers for the treatment of Vitiligo | |
140 | Liposomal Cefoperazone inhalable formulation for biofilm eradication | |
141 | Localized delivery of repurposed Ketoconazole using nanostructured lipid carriers-based gel: A potential strategy for skin cancer treatment. | |
142 | Luliconazole nanocrystal embedded nanogel: Formulation, characterization and in-vitro evaluation | |
143 | Mangiferin based niosomal in situ gel: Formulation and characterization | |
144 | Mesoporous silica as a carrier for amorphous solid dispersion of Itraconazole | |
145 | Microparticles for colonic controlled drug delivery | |
146 | Mitochondria-targeted docetaxel loaded dqasomes for the treatment of multi-drug resistant breast tumor: In vitro and in vivo studies. | |
147 | Modulating solid state characteristics of SGLT-2 inhibitors via cocrystals approach | |
148 | Myricetin loaded cross linked oral chitosan nanoparticles for the management of Type 2 Diabetes | |
149 | Nanogold Berberine: Enhanced efficacy in a tumor microenvironment simulating 3D spheroid model | |
150 | Nanoliposomes embedded nanocochleates for improving Artemether lumefantrine oral bioavailability | |
151 | Nasal Donepezil Cubosomes: A novel realm in Alzheimer’s therapy | |
152 | Nose-to-brain delivery of Atazanavir sulfate and Resveratrol loaded NLC for the treatment of HIV latency in CNS | |
153 | Novel nanofiber insert for management of Dry Eye disease | |
154 | Numerical modelling of nutrient medium transport and drug diffusion in human microphysiological skin system for preclinical evaluation of drugs | |
155 | Oa-g4 dnps and nac-g4 dnps nanoparticulate system(s) for nose to brain delivery: Potentiated inhibition of choline esterase and amyloid fibril formation to treat Alzheimer’s disease | |
156 | Optimization and characterization of lipid-based nanocarriers for the treatment of Amyotrophic lateral sclerosis | |
157 | Oral bioavailability enhancement of Niclosamide to explore its repurposing potential | |
158 | Paclitaxel and Imatinib Tosylate coloaded PLGA nanoparticles coated with protamine having promising efficacy on breast cancer cell line | |
159 | Pharmacodynamic and pharmacokinetic studies of developed transdermal drug delivery system of Mirtazapine | |
160 | Pharmacokinetic assessment and mucosal toxicity study of vaginal multipurpose prevention technology | |
161 | Polycystic ovary syndrome treatments: Bilayer tablet | |
162 | Polymer based antimicrobial herbal essential oil coatings as potential urethral biomaterial: Preparation and in vitro evaluation | |
163 | Polyvinylpyrrolidone and carnauba wax based extended-release oral formulations of a liquid drug Valproic acid | |
164 | Precision drug discovery from Zingiber officinalis: Unraveling therapeutic insights for Rheumatoid Arthritis through innovative in-silico approaches and controlled release strategies | |
165 | Preparation and characterisation of microneedle scleral patch for minimally invasive delivery of regorafenib to treat choroidal neovascularization | |
166 | Preparation and characterization of canagliflozin-loaded nanostructured lipid carriers (NLC) for improved oral bioavailability | |
167 | Preparation and evaluation of niosomal Luliconazole gel for topical drug delivery | |
168 | Pulmonary delivery of spray-dried gelatin microspheres with improved solubility and controlled release of Lovastatin | |
169 | QbD enabled Solid Dispersion of single ethoxylated solubilizer, soluplus for enhanced solubility and permeability of BCS IV drugs | |
170 | Repurposed-Mebendazole loaded nano-structured lipid carriers-based gel: A promising approach in skin cancer treatment | |
171 | Revolutionizing biofilm treatment: Bacteriophage microparticles in topical gel | |
172 | Rivaroxaban eutectics with improved solubility, dissolution rates, bioavailability and stability | |
173 | Sesamol – hydroxypropyl β-cyclodextrin loaded polymeric hydrogel for wound healing | |
174 | Sinuflora: A nasal synbiotic formulation for prophylactic and therapeutic management of nasal infections | |
175 | Soluplus based Apixaban solid dispersion: Optimization, ex-vivo permeability, and in-vivo pharmacokinetic studies | |
176 | Spray dried mucoadhesive microspheres of Tapentadol Hydrochloride: Development, characterization and evaluation | |
177 | Stability enhancement using cyclodextrin complexation: an in vitro-in silico correlation | |
178 | Stimuli responsive polymeric carriers for targeted drug delivery of anti-acne agent | |
179 | Studies on cocrystallization of poorly water soluble drug for solubility enhancement | |
180 | Studies on ionic liquids of Acyclovir as penetration enhancer in transdermal drug delivery system. | |
181 | Studies on mucoadhesive intranasal nanoemulsions of Iloperidone for brain delivery | |
182 | Studies on polyelectrolyte complex based nanoparticles of water soluble drug for Uveitis | |
183 | Studies on thermoresponsive and mucoadhesive gels of Anti-Parkinson’s drug for nasal delivery | |
184 | Surface spiked lipidic nanocarriers for the brain targeted drug delivery through intranasal route | |
185 | Sustained delivery of Interleukin-1 receptor antagonist (IL-1Ra) using polymeric nanocomplexes for the treatment of Type 1 Diabetes Mellitus | |
186 | Synthesis and characterization of Bimetallic Au-Ag nanoparticles loaded nanofibers for the potential treatment against antimicrobial resistance bacteria | |
187 | Tamoxifen-loaded solid lipid nanoparticles conjugated with N-acetyl-D-glucosamine for improved targeted delivery in breast cancer | |
188 | Targeted delivery of Palbociclib Loaded Chitosan-g-estrone Nanoparticles for hypoxic Breast Tumour: Development, in vivo optical and ultrasound/photoacoustic Imaging | |
189 | Targeted Pulmonary Tuberculosis therapy: development and evaluation of spray-dried microspheres loaded dry powder for inhalation | |
190 | Ternary solid dispersion system of Etoricoxib for improving its solubility | |
191 | Formulation and development of Irinotecan loaded spherulites | |
192 | Unveiling the anti-cancer potency of ferroptosis and apoptosis inducing agents through a targeted co-delivery system | |
193 | Vaginal suppository of Lawsone inclusion complex for treatment and prophylaxis of vaginal candidiasis | |
194 | Αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of Docetaxel against breast cancer |